Clinical and laboratory predictors of immune checkpoint inhibitor efficacy in non-small cell lung cancer

被引：0
|
作者：
Christopoulos, P. [1 ]
Kohlhaeufl, J. [1 ]
Bozorgmehr, F. [1 ]
Kuon, J. [1 ]
Schneider, M. [1 ]
Neumann, O. [1 ]
Liersch, S. [1 ]
Heussel, C. [1 ]
Winter, H. [1 ]
Herth, F. [1 ]
Rieken, S. [2 ]
Muley, T. [1 ]
Meister, M. [1 ]
Bischoff, H. [1 ]
Lasitschka, F. [1 ]
Stenzinger, A. [3 ]
Thomas, M. [1 ]
机构：
[1] Thoraxklin Heidelberg, Oncol, Heidelberg, Germany
[2] Univ Hosp Heidelberg, Radiat Oncol, Heidelberg, Germany
[3] Univ Hosp Heidelberg, Inst Pathol, Heidelberg, Germany
来源：
ANNALS OF ONCOLOGY | 2018年 / 29卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
10P
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Immune checkpoint inhibitors in non-small cell lung cancer
    Eberhardt, Wilfried Ernst Erich
    ONKOLOGE, 2017, 23 (10): : 838 - 844
  • [32] Immune Checkpoint Therapy in Non-Small Cell Lung Cancer
    Marrone, Kristen A.
    Brahmer, Julie R.
    CANCER JOURNAL, 2016, 22 (02): : 81 - 91
  • [33] Immune Checkpoint Inhibitors in Non-Small Cell Lung Cancer
    Herzberg, Benjamin
    Campo, Meghan J.
    Gainor, Justin F.
    ONCOLOGIST, 2017, 22 (01): : 81 - 88
  • [34] RE: Smoking History as a Potential Predictor of Immune Checkpoint Inhibitor Efficacy in Metastatic Non-Small Cell Lung Cancer
    Hopkins, Ashley M.
    Kichenadasse, Ganessan
    Logan, Jessica M.
    Rowland, Andrew
    Sorich, Michael J.
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2022, 114 (03): : 475 - 476
  • [35] Impact of bowel movement condition on immune checkpoint inhibitor efficacy in patients with advanced non-small cell lung cancer
    Katayama, Yuki
    Yamada, Tadaaki
    Tanimura, Keiko
    Yoshimura, Akihiro
    Takeda, Takayuki
    Chihara, Yusuke
    Tamiya, Nobuyo
    Kaneko, Yoshiko
    Uchino, Junji
    Takayama, Koichi
    THORACIC CANCER, 2019, 10 (03) : 526 - 532
  • [36] The relationship between evolving sarcopenia and efficacy of immune checkpoint inhibitor in non-small cell lung cancer patients.
    Makiguchi, Tomonori
    Tanaka, Hisashi
    Taima, Kageaki
    Tatsuo, Soichiro
    Iida, Saya
    Kakeda, Shingo
    Tasaka, Sadatomo
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [37] Comprehensive analysis of the tumor immune micro-environment in non-small cell lung cancer for efficacy of checkpoint inhibitor
    Seo, Jeong-Sun
    Kim, Ahreum
    Shin, Jong-Yeon
    Kim, Young Tae
    SCIENTIFIC REPORTS, 2018, 8
  • [38] Comprehensive analysis of the tumor immune micro-environment in non-small cell lung cancer for efficacy of checkpoint inhibitor
    Jeong-Sun Seo
    Ahreum Kim
    Jong-Yeon Shin
    Young Tae Kim
    Scientific Reports, 8
  • [39] Immune checkpoint blockade and biomarkers of clinical response in non-small cell lung cancer
    Hallqvist, Andreas
    Rohlin, Anna
    Raghavan, Sukanya
    SCANDINAVIAN JOURNAL OF IMMUNOLOGY, 2020, 92 (06)
  • [40] Tobacco Use and Response to Immune Checkpoint Inhibitor Therapy in Non-Small Cell Lung Cancer
    Corke, Lucy K.
    Li, Janice J. N.
    Leighl, Natasha B.
    Eng, Lawson
    CURRENT ONCOLOGY, 2022, 29 (09) : 6260 - 6276
12345